Cargando…

Alterations in gut microbiota and host transcriptome of patients with coronary artery disease

BACKGROUND: Coronary artery disease (CAD) is a widespread heart condition caused by atherosclerosis and influences millions of people worldwide. Early detection of CAD is challenging due to the lack of specific biomarkers. The gut microbiota and host-microbiota interactions have been well documented...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liuying, Mou, Xuanting, Li, Jingjing, Li, Miaofu, Ye, Caijie, Gao, Xiaofei, Liu, Xiaohua, Ma, Yunlong, Xu, Yizhou, Zhong, Yigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623719/
https://www.ncbi.nlm.nih.gov/pubmed/37924005
http://dx.doi.org/10.1186/s12866-023-03071-w
_version_ 1785130793763340288
author Chen, Liuying
Mou, Xuanting
Li, Jingjing
Li, Miaofu
Ye, Caijie
Gao, Xiaofei
Liu, Xiaohua
Ma, Yunlong
Xu, Yizhou
Zhong, Yigang
author_facet Chen, Liuying
Mou, Xuanting
Li, Jingjing
Li, Miaofu
Ye, Caijie
Gao, Xiaofei
Liu, Xiaohua
Ma, Yunlong
Xu, Yizhou
Zhong, Yigang
author_sort Chen, Liuying
collection PubMed
description BACKGROUND: Coronary artery disease (CAD) is a widespread heart condition caused by atherosclerosis and influences millions of people worldwide. Early detection of CAD is challenging due to the lack of specific biomarkers. The gut microbiota and host-microbiota interactions have been well documented to affect human health. However, investigation that reveals the role of gut microbes in CAD is still limited. This study aims to uncover the synergistic effects of host genes and gut microbes associated with CAD through integrative genomic analyses. RESULTS: Herein, we collected 52 fecal and 50 blood samples from CAD patients and matched controls, and performed amplicon and transcriptomic sequencing on these samples, respectively. By comparing CAD patients with health controls, we found that dysregulated gut microbes were significantly associated with CAD. By leveraging the Random Forest method, we found that combining 20 bacteria and 30 gene biomarkers could distinguish CAD patients from health controls with a high performance (AUC = 0.92). We observed that there existed prominent associations of gut microbes with several clinical indices relevant to heart functions. Integration analysis revealed that CAD-relevant gut microbe genus Fusicatenibacter was associated with expression of CAD-risk genes, such as GBP2, MLKL, and CPR65, which is in line with previous evidence (Tang et al., Nat Rev Cardiol 16:137-154, 2019; Kummen et al., J Am Coll Cardiol 71:1184-1186, 2018). In addition, the upregulation of immune-related pathways in CAD patients were identified to be primarily associated with higher abundance of genus Blautia, Eubacterium, Fusicatenibacter, and Monoglobus. CONCLUSIONS: Our results highlight that dysregulated gut microbes contribute risk to CAD by interacting with host genes. These identified microbes and interacted risk genes may have high potentials as biomarkers for CAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-023-03071-w.
format Online
Article
Text
id pubmed-10623719
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106237192023-11-04 Alterations in gut microbiota and host transcriptome of patients with coronary artery disease Chen, Liuying Mou, Xuanting Li, Jingjing Li, Miaofu Ye, Caijie Gao, Xiaofei Liu, Xiaohua Ma, Yunlong Xu, Yizhou Zhong, Yigang BMC Microbiol Research BACKGROUND: Coronary artery disease (CAD) is a widespread heart condition caused by atherosclerosis and influences millions of people worldwide. Early detection of CAD is challenging due to the lack of specific biomarkers. The gut microbiota and host-microbiota interactions have been well documented to affect human health. However, investigation that reveals the role of gut microbes in CAD is still limited. This study aims to uncover the synergistic effects of host genes and gut microbes associated with CAD through integrative genomic analyses. RESULTS: Herein, we collected 52 fecal and 50 blood samples from CAD patients and matched controls, and performed amplicon and transcriptomic sequencing on these samples, respectively. By comparing CAD patients with health controls, we found that dysregulated gut microbes were significantly associated with CAD. By leveraging the Random Forest method, we found that combining 20 bacteria and 30 gene biomarkers could distinguish CAD patients from health controls with a high performance (AUC = 0.92). We observed that there existed prominent associations of gut microbes with several clinical indices relevant to heart functions. Integration analysis revealed that CAD-relevant gut microbe genus Fusicatenibacter was associated with expression of CAD-risk genes, such as GBP2, MLKL, and CPR65, which is in line with previous evidence (Tang et al., Nat Rev Cardiol 16:137-154, 2019; Kummen et al., J Am Coll Cardiol 71:1184-1186, 2018). In addition, the upregulation of immune-related pathways in CAD patients were identified to be primarily associated with higher abundance of genus Blautia, Eubacterium, Fusicatenibacter, and Monoglobus. CONCLUSIONS: Our results highlight that dysregulated gut microbes contribute risk to CAD by interacting with host genes. These identified microbes and interacted risk genes may have high potentials as biomarkers for CAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-023-03071-w. BioMed Central 2023-11-03 /pmc/articles/PMC10623719/ /pubmed/37924005 http://dx.doi.org/10.1186/s12866-023-03071-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Liuying
Mou, Xuanting
Li, Jingjing
Li, Miaofu
Ye, Caijie
Gao, Xiaofei
Liu, Xiaohua
Ma, Yunlong
Xu, Yizhou
Zhong, Yigang
Alterations in gut microbiota and host transcriptome of patients with coronary artery disease
title Alterations in gut microbiota and host transcriptome of patients with coronary artery disease
title_full Alterations in gut microbiota and host transcriptome of patients with coronary artery disease
title_fullStr Alterations in gut microbiota and host transcriptome of patients with coronary artery disease
title_full_unstemmed Alterations in gut microbiota and host transcriptome of patients with coronary artery disease
title_short Alterations in gut microbiota and host transcriptome of patients with coronary artery disease
title_sort alterations in gut microbiota and host transcriptome of patients with coronary artery disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623719/
https://www.ncbi.nlm.nih.gov/pubmed/37924005
http://dx.doi.org/10.1186/s12866-023-03071-w
work_keys_str_mv AT chenliuying alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT mouxuanting alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT lijingjing alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT limiaofu alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT yecaijie alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT gaoxiaofei alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT liuxiaohua alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT mayunlong alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT xuyizhou alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease
AT zhongyigang alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease